Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.8M Sell
89,732
-11,921
-12% -$2.56M 3.38% 10
2026
Q1
$22.5M Sell
101,653
-6,775
-6% -$1.66M 3.97% 10
2025
Q4
$27.7M Sell
108,428
-4,761
-4% -$1.2M 4.17% 10
2025
Q3
$28M Buy
113,189
+86
+0.1% +$20.6K 4.18% 6
2025
Q2
$27.2M Sell
113,103
-1,425
-1% -$332K 3.85% 7
2025
Q1
$26M Buy
+114,528
New +$25.2M 3.66% 12

Other funds holding STE

Foresight Group's STE Position: Q2 2026 in Review

Foresight Group reduced its Steris (STE) stake by 12% in Q2 2026, selling an estimated $2.56M and leaving 89,732 shares worth $18.8M. The position accounts for 3.38% of the portfolio, ranked #10.

Foresight Group first reported a position in STE in Q1 2025 and has held it in 6 quarters since. The position peaked at $28M in Q3 2025. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Foresight Group held 89,732 shares of Steris worth $18.8M as of Q2 2026.
  • Foresight Group sold 11,921 Steris shares in Q2 2026, an estimated $2.56M.
  • Steris made up 3.38% of Foresight Group's portfolio in Q2 2026, its #10 holding.
  • Foresight Group first reported a position in Steris in Q1 2025 and has held it in 6 quarters since.
  • Foresight Group's Steris position peaked at $28M in Q3 2025.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Foresight Group's 13F filing for Q2 2026, filed 27 Jul 2026.